Related Experiment Video
Updated: May 5, 2026

06:40
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
Published on: July 28, 2023
4.6K
Summary
Fasting serum pyridoxal levels were low in most patients with active gastric ulcers but not with duodenal ulcers. This suggests a potential link between vitamin B6 deficiency and gastric ulceration.
Area of Science:
- Biochemistry
- Gastroenterology
- Nutritional Science
Background:
- Peptic ulcer disease affects millions globally.
- The role of specific vitamin deficiencies in peptic ulcer pathogenesis requires further elucidation.
- Pyridoxal (a form of vitamin B6) is crucial for various metabolic processes.
Purpose of the Study:
- To investigate fasting serum pyridoxal levels in patients with active peptic ulceration.
- To determine if pyridoxal levels differ between gastric and duodenal ulcers.
Main Methods:
- Assay of fasting serum pyridoxal using an automated microbiological system.
- Inclusion of 50 patients with endoscopically confirmed active peptic ulcers (gastric, duodenal, pyloric canal).
Main Results:
- Low serum pyridoxal was observed in 28 out of 30 patients with gastric ulcers.
- Only one patient with a duodenal ulcer had low serum pyridoxal.
- No significant differences in age, sex, drug/alcohol intake, or diet were found between gastric and duodenal ulcer groups.
Conclusions:
- Fasting serum pyridoxal deficiency is common in patients with active gastric ulcers.
- Pyridoxal deficiency may be associated with gastric ulceration, unlike duodenal ulceration.
- Further research is warranted to explore the implications of vitamin B6 status in peptic ulcer disease.
More Related Videos
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.6K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.6K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.4K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.4K
Peptic Ulcer Disease I: Introduction
1.2K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
1.0K
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
1.0K
Peptic Ulcer Disease I: Introduction
65
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
65

